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Background: Evidence-based interventions and strategies are needed to improve child survival in countrieswith a
high burden of neonatal and childmortality. An overview of systematic reviews can focus implementation on the
most effective ways to increase child survival.
Methods: In this overviewwe includedpublished Cochrane and other systematic reviews of experimental and ob-
servational studies on antenatal, childbirth, postnatal and child health interventions aiming to prevent perinatal/
neonatal and childmortality using theWHO list of essential interventions.We assessed themethodological qual-
ity of the reviews using the AMSTAR criteria and assessed the quality of the outcomes using the GRADE approach.
Based on the ﬁndings fromGRADE criteria, interventionswere summarized as effective, promising or ineffective.
Findings: The overview identiﬁed 148 Cochrane and other systematic reviews on 61 reproductive, maternal,
newborn and child health interventions. Of these, only 57 reviews reported mortality outcomes. Using the
GRADE approach, antenatal corticosteroids for preventing neonatal respiratory distress syndrome in preterm
infants; early initiation of breastfeeding; hygienic cord care; kangaroo care for preterm infants; provision and
promotion of use of insecticide treated bed nets (ITNs) for children; and vitamin A supplementation for infants
from six months of age, were identiﬁed as clearly effective interventions for reducing neonatal, infant or child
mortality. Antenatal care, tetanus immunization in pregnancy, prophylactic antimalarials during pregnancy,
induction of labour for prolonged pregnancy, case management of neonatal sepsis, meningitis and pneumonia,
prophylactic and therapeutic use of surfactant, continuous positive airway pressure for neonatal resuscitation,
case management of childhood malaria and pneumonia, vitamin A as part of treatment for measles associated
pneumonia for children above 6months, and home visits across the continuum of care, were identiﬁed as prom-
ising interventions for reducing neonatal, infant, child or perinatal mortality.
Interpretation: Comprehensive adoption of the above six effective and 11 promising interventions can improve
neonatal and child survival around the world. Choice of intervention and degree of implementation currently
depends on resources available and policies in individual countries and geographical settings.
Funding: This review was part of doctoral thesis which was funded by University of Adelaide, Australia.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The global burden of neonatal and child mortality is alarmingly high
in low and middle income countries (LMICs). There has been a sharp
decline in mortality rates in children under ﬁve years of age between
1990 and 2013 (from 90 mortalities per 1000 down to 46 mortalities
per 1000 live births between 1990 and 2013). This rate needs to furthersi),
c.nz (C. Crowther),
. Bhutta).
. This is an open access article underdecrease, to just 30 mortalities per 1000 live births, in order to meet
the Millennium Development Goals (MDGs) 2015 target (You et al.,
2013).
Despite all the progress made in the last decade, it is very unlikely
that the MDG targets will be met in many LMICs, where 99% of global
deaths occur (You et al., 2013). In countries with a high burden of
neonatal and child mortality, a variety of interventions could substan-
tially reduce deaths and improve maternal and perinatal outcomes.
Interventions and care primarily employed during different periods
from antenatal to the later childhood period can facilitate reductions
in neonatal and later mortality. However, a major obstacle in meeting
the proposed reduction is thatmost neonatal and child health programs
do not reach to those who need it the most. Therefore, effectivethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Panel 1
List of interventions reviewed.
Pre pregnancy interventions
Family planning
Prevention and management of sexually transmitted infections including HIV
Folic acid fortiﬁcation and/or supplementation
Pregnancy interventions
Antenatal care
Iron and folic acid supplementation during pregnancy
Tetanus immunization in pregnancy
Prophylactic antimalarial and insecticide treated bednets for preventing malaria in
pregnancy
Interventions for smoking cessation during pregnancy
Screening and treatment of syphilis
Prevention and management of HIV and prevention of mother to child
transmission in pregnancy
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all and be delivered across the continuum of reproductive, maternal,
neonatal and child health (RMNCH) care.
As we approach the deadline for the target of the MDGs and
begin the journey towards achieving sustainable development
goals (SDGs) we must focus efforts on programs and interventions
shown to work. Several systematic reviews have evaluated the role
of individual antenatal, natal, postnatal and child health interven-
tions and their potential role at improving morbidity and mortali-
ty, however, there has been no overview on these interventions.
Such an overview of systematic reviews of interventions to pre-
vent neonatal and child mortality would facilitate the development
of a deﬁnitive framework for preventing neonatal and child mor-
tality in LMICs.Calcium supplementation in pregnancy
Low-dose aspirin for the prevention of pre-eclampsia
Use of antihypertensive drugs for treating severe hypertension in pregnancy
Prevention and treatment of eclampsia
Reduce mal presentation at term using external cephalic version (N36 weeks)
Induction of labour for management of premature rupture of membranes at term.
Antibiotics for management of preterm rupture of membranes
Childbirth interventions
Corticosteroids for preventing neonatal respiratory distress syndrome
Management of unintended pregnancy
Social support during childbirth
Prophylactic antibiotic for caesarean-section
Prevention of postpartum haemorrhage: prophylactic uterotonic to prevent
postpartum haemorrhage
Active management of third stage of labour to prevent postpartum haemorrhage
Induction of labour for prolonged pregnancy
C-section for absolute maternal indication (e.g. obstructed labour and central
placenta previa)
Management of post-partum haemorrhage e.g. uterine massage
Uterotonics
Postpartum interventions
Advice and provision of family planning
Prevent, measure and treat maternal anaemia
Detection and management of postpartum sepsis
Screening and initiation or continuation of ARV therapy for HIV
Neonatal interventions
Promotion and provision of thermal care for all newborns to prevent
hypothermia
Promotion and support for early initiation and exclusive breastfeeding (within
the ﬁrst hour)
Promotion and provision of hygienic cord and skin care
Neonatal resuscitation with bag and mask for babies who do not breath at birth
Newborn immunization
Presumptive antibiotic therapy for the newborns at risk of bacterial infection
Case management of neonatal sepsis, meningitis and pneumonia
Kangaroo mother care for low birth babies
Extra support for feeding the small and preterm baby
Prophylactic and therapeutic use of surfactant to prevent respiratory distress
syndrome in pre-term babies
Continuous positive airway pressure (CPAP) to manage pre-term babies with
respiratory distress syndrome
Management of newborns with jaundice
Infant and child health interventions
Promotion and support for exclusive breastfeeding for 6 months
Continued breastfeeding up to 2 years and beyond
Appropriate complementary feeding starting at 6 months
Provision and promotion of use of insecticide treated bed nets for children
Case management of childhood malaria
Comprehensive care of children infected or exposed to HIV infection
Promote and provide routine immunization plus H. Inﬂuenza, meningococcal,
pneumococcal, and rotavirus vaccines
Vitamin A supplementation from 6 months of age in Vitamin A deﬁcient
populations
Management of severe acute malnutrition
Case management of childhood pneumonia
Vitamin A as part of treatment for measles-associated pneumonia for children
above 6 months
Vitamin A as part of treatment for non-measles-associated pneumonia for
children above 6 months
Case management of diarrhoea: Acute watery diarrhoea
Dysentery
Cross cutting intervention
Home visits across the continuum of care women's groups2. Methodology
In this overview of reviews, we have included all published
Cochrane and the most recent (most latest on the given subject) other
systematic reviews of randomized, non-randomized controlled trials
of interventions and observational studies aiming to prevent perinatal
(stillbirths + early neonatal mortality) or neonatal or child mortality
(or stillbirths where either of these were not reported). We included
interventions considered for improving neonatal and child survival
and provided during pre-pregnancy, antenatal, childbirth and postnatal
periods to mothers or the infant or child included in a set of 61 RMNCH
interventions reported as essential interventions for reproductive,
maternal, newborn and child health by the World Health Organization
(WHO) (Panel 1) (Pmnch, 2011). We considered reviews that included
women of reproductive age, including pregnant women at any stage of
gestation, their newborns and children up to ﬁve years of age. This
overview considered reviews on interventions which were compared
against no placebo or treatment or control group (unless otherwise
indicated).
All available recent non-Cochrane and updated or most recent
Cochrane systematic reviews were identiﬁed from the Cochrane
Library and PubMed using the search strategy devised for each inter-
vention separately during Nov 2012 to Jan 2013 (Supplementary
Table 1). The search terms were limited to title, abstract, or keywords.
The methodology for data collection and analysis is based on the
Cochrane Handbook of Systematic Reviews of Interventions (Higgins
and Green, 2011). The outcomes of interest for this overview of
reviews were perinatal mortality, neonatal mortality, infant mortality
and under-ﬁve mortality reported as primary or secondary outcomes
in included reviews.
The protocol for this overview is registered with PROSPERO 2014:
CRD42014007091 (http://www.crd.york.ac.uk/PROSPERO/display_
record.asp?ID=CRD42014007091#.U75a1RCLMiw). Two review
authors (ZSL and PM) independently assessed the inclusion of all the po-
tential systematic reviews and extracted information using a predeﬁned
form (intervention, comparison, mortality outcome, type of studies in-
cluded — Characteristics of included reviews Supplementary Table 2).
Any disagreement was resolved through discussion or, where required,
we consulted a third person. We addressed two different quality assess-
ments in this overview: the quality of evidence in the included reviews
(Table 1) using the Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE) approach (Guyatt et al., 2008; Oxman and
Group, 2004) and the methodological quality of the systematic reviews
using the ‘assessment of multiple systematic reviews’ (AMSTAR) mea-
surement tool (Shea et al., 2007) (Supplementary Table 3). We did not
update individual reviews. Where reviews did not prepare and report
mortality outcomes using GRADE-pro software (Brozek et al., 2008),
we formulated ‘summary of ﬁndings’ tables. The following criteria
were taken into account to grade the evidence: study limitations (risk
of bias for the outcome of interest), consistency of effect, imprecision,
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the included reviews into following categories.
• What works?
Effective interventions: indicating that the review found high quality
evidence with the effect likely to be similar to research ﬁndings.
• What might work?
Promising interventions (more evidence needed): indicating that the
review found moderate quality evidence with the effect expected to
be similar to research ﬁndings, but with a possibility that it will be
substantially different in the future.
• Insufﬁcient evidence to make judgement
Ineffective or probably ineffective interventions: indicating that the
review found low or very low quality evidence of effectiveness or
lack of effectiveness for an intervention.
For lowquality of evidence, it is likely that the effectwill be substantially
different from research ﬁndings, but that thesewill indicatewhatmight
be expected.
For very low quality of evidence, the anticipated effect is very uncertain
and the research does not provide a reliable indication ofwhatmight be
expected.
3. Funders and Their Role
This review was part of doctoral thesis which was funded by
University of Adelaide, Australia. The funders had no role in the study
design, study conduct, data analysis, data interpretation, or writing of
the report. All authors take responsibility for the integrity and the
accuracy of the data. The corresponding author had ﬁnal responsibility
to submit the report for publication.
4. Results
The overview included 61 reproductive (n = 3), maternal
(pregnancy: n = 15; childbirth: n = 11; postpartum: n = 4), new-
born (n = 12) and child (n = 16) health interventions to assess
their impact on neonatal and child survival (Panel 1). A total of 148
systematic reviews were identiﬁed for these 61 RMNCH interven-
tions, of which 92 were Cochrane reviews, 55 were non-Cochrane
reviews and one was a WHO guideline on management of unintended
pregnancy. Of these 148 reviews, only 57 reviews reported mortality
outcomes (Panel 2).
Using the GRADE approach, we identiﬁed six interventions to be
clearly effective in reducing neonatal, infant or child mortality
(corticosteroids for preventing neonatal respiratory distress syndrome
in preterm infants; early initiation of breastfeeding; hygienic cord care;
kangaroo care for preterm infants; provision and promotion of use of
insecticide treated bed nets (ITNs) for children; and vitamin A supple-
mentation for infants from six months of age).
We identiﬁed 11 promising interventions for reducing neonatal, in-
fant, child or perinatal mortality (antenatal care; tetanus immunization
in pregnancy; prophylactic antimalarial during pregnancy; induction of
labour for prolonged pregnancy; case management of neonatal sepsis,
meningitis and pneumonia; prophylactic and therapeutic use of
surfactant; continuous positive airway pressure; case management of
childhoodmalaria; casemanagement of childhood pneumonia; vitamin
A as part of treatment for measles associated pneumonia for children
above 6 months; and home visits across the continuum of care) and a
further four interventions were rated as promising for reducing
stillbirths (prophylactic antimalarial during pregnancy; provision and
promotion of ITNs during pregnancy; induction of labour for prolonged
pregnancy; and home visits across the continuum of care). Eighteen
interventions showed insufﬁcient evidence of beneﬁt in one or more
of the mortality categories (Table 1).4.1. Effective Interventions
4.1.1. Corticosteroids for Preventing Neonatal Respiratory Distress
Syndrome (RDS)
This overview identiﬁed three reviews (Mwansa-Kambafwile et al.,
2010; Roberts and Dalziel, 2006; Brownfoot et al., 2013), of which two
(Mwansa-Kambafwile et al., 2010; Roberts and Dalziel, 2006) reviewed
the impact of antenatal corticosteroids on the mother before anticipat-
ed preterm birth (with additional analysis for women in LMICs)
(Mwansa-Kambafwile et al., 2010). Brownfoot and colleagues
(Brownfoot et al., 2013) assessed different corticosteroid regimens.
Two reviews reported the impact of corticosteroids on neonatal mortal-
ity (Mwansa-Kambafwile et al., 2010; Roberts and Dalziel, 2006).
Roberts and Dalziel pooled 18 trials on 3956 women at risk of preterm
birth and found a 31% (Risk Ratio (RR) 0.69; 95% Conﬁdence Interval
(CI): 0.58, 0.81) reduction in neonatal mortality (high GRADE rating)
in women who were given antenatal corticosteroids compared to
women who were not given any corticosteroids or given placebo
(Roberts and Dalziel, 2006). Mwansa-Kambafwile and colleagues
(Mwansa-Kambafwile et al., 2010) reported a 31% (RR 0.69; 95% CI:
0.58, 0.81) reduction (high GRADE rating) in preterm-speciﬁc mortality
on pooling 18 trials on 3956womenmostly fromhigh-income countries
and 53% (RR 0.47; 95% CI: 0.35, 0.64) reduction in preterm-speciﬁc
mortality on pooling a subset of four trials on 672 women from
middle-income countries who were given antenatal corticosteroids.
4.1.2. Early Initiation of Breastfeeding
The overview identiﬁed six reviews (Dyson et al., 2005; Lewin et al.,
2010; Lassi et al., 2010; Imdad et al., 2011a; Debes et al., 2013;
Lumbiganon et al., 2012) that reported the impact of different interven-
tions on improving early initiation of breastfeeding. Lewin and
colleagues (Lewin et al., 2010) and Lassi and colleagues (Lassi et al.,
2010) assessed the impact of interventions delivered through lay health
workers and in the form of packages, respectively, on improving
breastfeeding rates. These reviews reported reductions in mortality;
however, reduction in deaths may have been achieved by other parts
of the intervention package and therefore the reduction does not
necessarily reﬂect the impact of a breastfeeding intervention alone.
Dyson and colleagues (Dyson et al., 2005), Imdad and colleagues
(Imdad et al., 2011a), and Lumbiganon and colleagues (Lumbiganon
et al., 2012) did not report outcomes on mortality. The review by
Debes and colleagues (Debes et al., 2013) identiﬁed 18 studies, of
which three prospective cohort studies (including 44,249 newborns)
with moderate GRADE quality showed neonatal mortality was reduced
by 44% (RR 0.56; 95% CI: 0.40, 0.79)with early initiation of breastfeeding
(within less than 24 h of birth).
4.1.3. Hygienic Cord Care
The overview identiﬁed two reviews, of which Zupan and
colleagues assessed topical cord care (Zupan et al., 2004) and the
other two by Imdad and colleagues assessed chlorhexidine applica-
tion alone and other application for cord care and included almost
similar studies (Imdad et al., 2013a,b). The latter two reported neona-
tal mortality (Imdad et al., 2013a,b). Pooled analysis of three studies
(n = 54,561) found a moderate GRADE quality and signiﬁcant 23%
(RR 0.77; 955 CI: 0.63, 0.94) reduction in neonatal mortality with
the application of chlorhexidine when compared with no application
to the umbilical cord (dry cord care) (Imdad et al., 2013a,b). However
the Cochrane review by Imdad and colleagues also compared washing
the cord with dry care, reporting no difference in all-cause mortality
(RR 1.00; 95% CI: 0.76, 1.32, moderate GRADE quality) (Imdad et al.,
2013b).
4.1.4. Kangaroo Mother Care for Preterm Infants
The overview identiﬁed two reviews (Lawn et al., 2010;
Conde-Agudelo and Díaz-Rossello, 2014) that assessed the impact of
Panel 2
GRADE interventions according to outcomes.
What works What might work Insufﬁcient evidence
Mortality (neonatal or infant or child)
Corticosteroid for prevention of neonatal
respiratory distress syndrome
Tetanus immunization in pregnancy (tetanus toxoid vs. placebo) Family planning
Early initiation of breastfeeding Prophylactic antimalarial during pregnancy Periconceptional folic acid supplementation
Hygienic cord care Induction of labour for prolonged pregnancy Folic acid supplementation during pregnancy⁎
Kangaroo mother care for low birth weight
babies
Case management of neonatal sepsis, meningitis and pneumonia Iron supplementation during pregnancy
Provision and promotion of use of
insecticide treated bed nets for children
Prophylactic and therapeutic use of surfactant Tetanus immunization in pregnancy (TT vs. diphtheria and
inﬂuenza)
Vitamin A supplementation from 6 months
of age
Continuous positive airway pressure (CPAP) Smoking cessation during pregnancy
Case management of childhood malaria Prevention and treatment of eclampsia
Case management of childhood pneumonia Active management for third stage of labour
Vitamin A as part of treatment for measles associated
pneumonia for children above 6 months
Induction of labour for PROM
Home visits across the continuum of care women's groups Antibiotic for PROM
Thermal care for all newborns
Neonatal resuscitation with bag and mask
Presumptive antibiotic therapy for newborns
Case management of childhood malaria (monthly sulfadoxine
pyrimethamine (SP) compared to standard 2-dose SP)
Comprehensive care of children infected or exposed to HIV
infection
Vitamin A as part of treatment for non-measles-associated
pneumonia for children above 6 months
Case management of diarrhoea
Perinatal mortality
Antenatal care Periconceptional folic acid supplementation vs. placebo
Prophylactic antimalarial during pregnancy Smoking cessation during pregnancy
Induction of labour for prolonged pregnancy Calcium supplementation
Home visits across the continuum of care women's groups Prevention and treatment of eclampsia
(MgSO4 vs. none or other)
External cephalic version
Induction of labour for PROM
Antibiotic for PROM⁎⁎
Corticosteroid for prevention of neonatal RDS (dexamethasone
versus betamethasone)
Stillbirths
Provision and promotion of ITNs⁎⁎⁎ Periconceptional folic acid supplementation vs. no
treatment/placebo
Prophylactic antimalarial during pregnancy Folic acid supplementation during pregnancy⁎
Induction of labour for prolonged pregnancy Smoking cessation during pregnancy
Home visits across the continuum of care women's groups
Interventions in bold indicate that the outcomes estimates were statistically signiﬁcant.
⁎ Stillbirths + neonatal mortality.
⁎⁎ Perinatal mortality or death before discharge.
⁎⁎⁎ Foetal loss (miscarriage and stillbirths).
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(b2000 g) and reported mortality outcome. Pooled analysis of 11 stud-
ies from 2167 infants reported a signiﬁcant 33% reduction in mortality
(moderate GRADE quality) at the latest follow up (RR 0.67; 95% CI:
0.48, 0.95) (Conde-Agudelo and Díaz-Rossello, 2014). The meta-
analysis of three randomized controlled trials (RCTs) (n = 1075) — a
subset of those pooled in the latest Cochrane review (Conde-Agudelo
and Díaz-Rossello, 2014) — that provided KMC to infants in the ﬁrst
week of life showed a signiﬁcant 51% reduction in neonatal mortality
(RR 0.49; 95% CI: 0.29, 0.82 — high GRADE quality) when compared to
standard care (Lawn et al., 2010). This review also pooled three
observational studies and found a similar beneﬁcial impact on neonatal
mortality (RR 0.68; 95% CI: 0.58, 0.79) (Lawn et al., 2010).4.1.5. Provision and Promotion of use of ITNs for Children
The overview identiﬁed one review that pooled ﬁve studies on
149,221 children and compared ITNs with control and found a signiﬁ-
cant 18% reduction in child mortality (RR 0.82; 95% CI: 0.76, 0.89 —
moderate GRADE quality) (Lengeler, 2004).4.1.6. Vitamin A Supplementation From 6 Completed Months of age
The overview identiﬁed three reviews from the same review authors
whoassessed the impact of vitaminA supplementation from sixmonths
of age, and reported neonatal mortality (Imdad et al., 2010, 2011b;
Mayo-Wilson et al., 2011). In the latest of these, pooling of 17 trials in-
cluding 194,795 children found that vitaminA supplementation is effec-
tive in reducing all-cause mortality by 24% (RR 0.76; 95% CI: 0.69, 0.83)
when compared with no treatment or placebo (Imdad et al., 2010). The
quality was high on GRADE analysis.4.2. Promising Interventions
4.2.1. Antenatal Care
The overview identiﬁed two reviews (Dowswell et al., 2010; Carroli
et al., 2001) assessing the impact of fewer than usual antenatal care
visits. This reviewofﬁve trials including 108,002 pregnantwomen iden-
tiﬁed that reduced number of antenatal care visits (ranged 4–9) was as-
sociated with 14% higher risk of perinatal mortality (RR 1.14; 95% CI:
1.00, 1.31) when compared with standard antenatal care visits (ranged
Table 1
Grading analysis of mortality outcomes from included reviews.
–
–
–
–
–
–
–
–
–
(continued on next page)
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than the standard number may be harmful. Another review, comparing
groupwith standard antenatal care did not detect signiﬁcant differences
in perinatal mortality (RR 0.59; 95% CI: 0.22, 1.52; 2 trials, n = 1315)
(Homer et al., 2012).
4.2.2. Tetanus Immunization in Pregnancy
The overview identiﬁed two reviews on tetanus toxoid (TT) vaccina-
tion versus placebo: Demicheli and colleagues (Demicheli et al., 2013)
compared TT vaccination with inﬂuenza and cholera vaccination,
whereas Blencowe and colleagues (Blencowe et al., 2010a) compared
TT immunization with no immunization. The comparison of TT with in-
ﬂuenza and cholera was judged as low quality and therefore included in
“insufﬁcient evidence interventions” section. The meta-analyses from
Blencowe and colleagues (Blencowe et al., 2010a) displayed a signiﬁ-
cant impact of TT immunization on reducing neonatal mortality when
compared with no immunization (RR 0.06; 95% CI: 0.02, 0.20; two
studies, n = 2146). This review pooled two studies, of which one was
an experimental trial and the other was an observational study.
4.2.3. Prophylactic Antimalarials During Pregnancy
The overview identiﬁed four reviews on prophylactic antimalarial
and intermittent preventive treatment (IPT) in pregnancy (Eisele
et al., 2010; Radeva-Petrova et al., 2014). Two reviews reported out-
comes on neonatal mortality and perinatal mortality (Eisele et al.,
2010; Radeva-Petrova et al., 2014), whereas one reported stillbirths
(Radeva-Petrova et al., 2014).
4.2.3.1. Neonatal Mortality. Radeva-Petrova and colleagues assessed
antimalarial drug prophylaxis (e.g. chloroquine given weekly) or IPT
(typically sulfadoxine-pyrimethamine given two to three times during
pregnancy) with no regular or routine antimalarial or comparator IPT
and found a non-signiﬁcant 7% reduction in neonatal and infant mortal-
ity (RR 0.93; 95% CI: 0.76, 1.14 — low GRADE quality) on pooling nine
trials including 10,486 women in their ﬁrst or second pregnancy
(Radeva-Petrova et al., 2014). The review by Eisele and colleagues
compared IPT with control and found a non-signiﬁcant 17% reduction
in neonatal mortality (RR 0.83; 95% CI: 0.52, 1.20 — moderate GRADE
quality) (Eisele et al., 2010).
4.2.3.2. Perinatal Mortality. Radeva-Petrova and colleagues pooled six
trials on 6836 women in their ﬁrst or second pregnancy and found a
non-signiﬁcant 1% reduction in perinatal mortality (RR 0.99; 95% CI:
0.81, 1.22 — low GRADE quality) (Radeva-Petrova et al., 2014). Eisele
and colleagues found a non-signiﬁcant 17% reduction in perinatal
mortality (RR 0.83; 95% CI: 0.52, 1.20 — moderate GRADE quality)
(Eisele et al., 2010).
4.2.3.3. Stillbirths. Radeva-Petrova and colleagues pooled seven trials on
9833 women in their ﬁrst or second pregnancy and reported a non-
signiﬁcant increase in stillbirths (RR 1.01; 95% CI: 0.79, 1.28 — low
GRADE quality) (Radeva-Petrova et al., 2014).
4.2.4. Provision and Promotion of ITNs During Pregnancy
The overview identiﬁed two reviews by Gamble and colleagues
(Gamble et al., 2006, 2007) that studied the effect of ITN on pregnant
women and reported moderate GRADE quality foetal loss. Pooled
analysis of ﬁve trials reported a signiﬁcant 32% reduction in foetal loss
(miscarriage or stillbirths) (RR 0.68; 95% CI: 0.48, 0.98) (Gamble et al.,
2006). A subset of those trials pooled in the Cochrane review reported
a signiﬁcant 32% reduction in foetal loss (miscarriage or stillbirths) (RR
0.68; 95% CI: 0.48, 0.89; three studies, n = 4557) (Gamble et al., 2007).
4.2.5. Induction of Labour for Prolonged Pregnancy
The overview identiﬁed two reviews that evaluated the beneﬁts and
harms of a policy of labour induction at term or post-term comparedwith awaiting spontaneous labour or later induction of labour
(Gulmezoglu et al., 2012; Hussain et al., 2011). Both of the reviews in-
cluded almost the same set of studies and reported outcomes on perina-
tal mortality and stillbirths (Gulmezoglu et al., 2012; Hussain et al.,
2011), while only Gulmezoglu and colleagues reported neonatal
mortality (Gulmezoglu et al., 2012).
4.2.5.1. Neonatal Mortality. The meta-analysis by Gulmezoglu and
colleagues found a moderate GRADE quality non-signiﬁcant 63% (RR
0.37; 95% CI: 0.10, 1.38; 17 studies, n.7407) reduction in neonatal deaths
within seven days when compared with labour induction at term or
post-termwith awaiting spontaneous labour or later induction of labour
(Gulmezoglu et al., 2012).
4.2.5.2. Perinatal Mortality. The meta-analysis of 17 studies on 7407
women by Gulmezoglu and colleagues found a signiﬁcant 69% (RR
0.31; 95% CI: 0.12, 0.81 — moderate GRADE quality) (Gulmezoglu
et al., 2012) andmeta-analysis of 14 studies on 6597women byHussain
and colleagues found a signiﬁcant 69% (RR 0.31; 95% CI: 0.11, 0.88 —
moderate GRADE) (Hussain et al., 2011) reduction in perinatal mortality
with induced labour at term or post-term.
4.2.5.3. Stillbirths. The meta-analysis of 17 studies on 7407 women by
Gulmezoglu and colleagues found a non-signiﬁcant 70% (RR 0.30; 95%
CI: 0.08, 1.08 — moderate GRADE quality) (Gulmezoglu et al., 2012)
and meta-analysis of 14 studies on 6597 women by Hussain and col-
leagues found a 71% (RR 0.29; 95% CI: 0.06, 1.38 — moderate GRADE
quality) (Hussain et al., 2011) reduction in stillbirths.
4.2.6. Case Management of Neonatal Sepsis, Meningitis and Pneumonia
The overview identiﬁed four reviews that assessed the impact of
case management of diagnosed sepsis, meningitis and pneumonia
among neonates (Gordon and Jeffery, 2005; Sazawal and Black, 2003a;
Zaidi et al., 2011; Bhutta et al., 2009a). Among these, two reviews re-
ported an impact on mortality which was moderate on GRADE quality
(Zaidi et al., 2011; Bhutta et al., 2009a). Case management of neonatal
infectious diseases reported 27% (RR 0.73; 95% CI: 0.65, 0.82) (Bhutta
et al., 2009a) and 25% (RR 0.75, 95% CI: 0.64, 0.89; 4 studies) (Zaidi
et al., 2011) reduction in all-cause mortality. Similarly, the reviews
also reported reduction in pneumonia speciﬁc mortality by 42% (RR
0.58; 95% CI: 0.43, 0.78) (Bhutta et al., 2009a) and (RR 0.58; 95% CI:
0.41, 0.82; 3 studies) (Zaidi et al., 2011).
4.2.7. Prophylactic and Therapeutic use of Surfactant
The overview identiﬁed three reviews on the impact of prophylactic
and therapeutic use of surfactant and reportedmoderate quality GRADE
outcomes on neonatal mortality (Soll and Ozek, 2009; Soll, 1998;
Bahadue and Soll, 2012). Soll pooled six studies on 2352 newborns
that compared synthetic surfactant with placebo and found a signiﬁcant
27% reduction in neonatal mortality (RR 0.73; 95% CI: 0.61, 0.88) (Soll,
1998). Soll and Ozek assessed the impact of multiple doses of surfactant
with single dose from three trials on 1220 newborns with severe RDS
and found a signiﬁcant 41% reduction in neonatal mortality (RR 0.59;
95% CI: 0.44, 0.78) (Soll and Ozek, 2009). Bahadue and Soll compared
early versus delayed selective surfactant treatment for RDS from six
studies (n = 3577) and found a signiﬁcant 16% reduction in neonatal
mortality (RR 0.84; 95% C: 0.74, 0.95) (Bahadue and Soll, 2012).
4.2.8. Continuous Positive Airway Pressure (CPAP)
The overview identiﬁed three reviews (Greenough et al., 2008;
Lemyre et al., 2002; Ho et al., 2002; Subramaniam et al., 2005), of
which two reported mortality as an outcome (Greenough et al., 2008;
Ho et al., 2002; Subramaniam et al., 2005). Greenough 2008 compared
high frequencypositive pressure ventilation (HFPPV)with conventional
ventilation (CMV) and reported a non-signiﬁcant 20% reduction in
neonatal mortality (RR 0.80; 95% CI: 0.62, 1.03; three studies, n =
997Z.S. Lassi et al. / EBioMedicine 2 (2015) 985–1000585 — moderate GRADE) (Greenough et al., 2008). Ho and colleagues
compared continuous distending pressure (CDP) with standard care
and found a signiﬁcant 48% reduction in neonatal mortality (RR 0.52;
95% CI: 0.32, 0.87; six studies, n = 355 — moderate GRADE) (Ho et al.,
2002). Subramaniam and colleagues, compared prophylactic CPAP
with control and reported an increase in neonatak deaths with prophy-
lactic use (RR 1.29; 95% CI: 0.45, 3.67 — low GRADE) (Subramaniam
et al., 2005).
4.2.9. Case Management of Childhood Malaria
The overview identiﬁed four reviews (Eisele et al., 2010;Meremikwu
et al., 2012; Thwing et al., 2011), of which Thwing and colleagues report-
ed a reduction in malaria mortality in children 1 to 23 months (RR 0.01;
95% CI: 0.00, 0.06) and in children 24 to 59 months of age (RR 0.03; 95%
CI: 0.01, 0.14 — moderate GRADE quality) (Thwing et al., 2011).
Meremikwu and colleagues compared IPT versus placebo or no IPT and
reported a non-signiﬁcant reduction in child mortality (RR 0.66; 95%
CI: 0.31, 1.39; six studies, n = 9533 — moderate GRADE quality)
(Meremikwu et al., 2012).
4.2.10. Case Management of Childhood Pneumonia
The overview identiﬁed four reviews (Theodoratou et al., 2010;
Sazawal and Black, 2003b; Lamberti et al., 2013; Das et al., 2013), of
which two reviews reported mortality as an outcome. Both of these
reviews reported a signiﬁcant reduction in acute lower respiratory
tract infections (ALRI) speciﬁc mortality (RR 0.65; 95% CI: 0.52, 0.82;
nine studies) (Theodoratou et al., 2010); (RR 0.65; 95% CI: 0.52, 0.82)
(Das et al., 2013) and all-cause mortality (RR 0.79; 95% CI: 0.70, 0.82;
nine studies);Theodoratou et al., 2010 (RR 0.68; 95% CI: 0.53, 0.86)
(Das et al., 2013)with casemanagement of pneumoniawhen compared
to standard or no care. The evidence was moderate quality on GRADE
analysis.
4.2.11. Vitamin A as Part of Treatment for Measles-Associated Pneumonia
for Children Above 6 Months
The overview identiﬁed two reviews (Fawzi et al., 1993; Sudfeld
et al., 2010), of which one reported mortality (Fawzi et al., 1993). This
review pooled eight studies on 135,609 children and compared vitamin
A supplementation with none for measles associated pneumonia and
reported a signiﬁcant 30% reduction in child mortality (RR 0.70; 95 CI:
0.56, 0.87— moderate GRADE quality) (Fawzi et al., 1993).
4.2.12. Home Visits Across the Continuum of Care women's Groups
The overview identiﬁed four reviews (Lassi et al., 2010; Kidney et al.,
2009; Bhutta et al., 2009b; Gogia and Sachdev, 2010). Only two reviews
(Lassi et al., 2010; Gogia and Sachdev, 2010) assessed homevisitation as
part of delivery strategy. Both of these reviews reported outcome on
neonatal mortality (Lassi et al., 2010; Gogia and Sachdev, 2010),
whereas only one reported outcomes on perinatal mortality and
stillbirths (Lassi et al., 2010).
4.2.12.1. NeonatalMortality. The review by Lassi and colleagues reported
a 22% reduction in neonatal mortality (RR 0.78; 95% CI: 0.67, 0.92 —
moderate GRADE quality) on poolingﬁve studies on 56,878 participants
(Lassi et al., 2010). On the other hand, Gogia 2010 pooled ﬁve studies
and reported a 38% reduction in neonatal mortality (RR 0.62; 95% CI:
0.44, 0.87— moderate GRADE quality) (Gogia and Sachdev, 2010).
4.2.12.2. Perinatal Mortality. The review by Lassi and colleagues pooled
three studies on 45,835 participants and reported a 28% reduction in
perinatal mortality (RR 0.72; 95% CI: 0.61, 0.85 — moderate GRADE
quality) (Lassi et al., 2010).
4.2.12.3. Stillbirths. The review by Lassi and colleagues pooled three
studies on 45,835 participants and reported a 27% reduction instillbirths (RR 0.73; 95% CI: 0.67, 0.81 — moderate GRADE quality)
(Lassi et al., 2010).
4.3. Ineffective or probably ineffective interventions
Panel 2 reports the list of interventions which were low or very low
on GRADE quality and thus were categorized as interventions with in-
sufﬁcient evidence. Some of those interventions reported their impact
on stillbirths, perinatal or neonatal mortality and those includes family
planning (Kozuki et al., 2013), periconceptional folic acid supplementa-
tion (Blencowe et al., 2010b, De-Regil et al., 2010), folic acid supplemen-
tation during pregnancy (Lassi et al., 2013b, Pena-Rosas et al., 2012),
smoking cessation during pregnancy (Coleman et al., 2012,
Chamberlain et al., 2013), calcium supplementation during pregnancy
(Imdad et al., 2011c, Hofmeyr et al., 2014), magnesium sulphate com-
pared to phenytoin for prevention and management of pre-eclampsia
(Duley et al., 2010a, Duley et al., 2010b, Duley et al., 2010c, Duley et
al., 2010d), external cephalic version (Cluver et al., 2012, Hofmeyr et
al., 2003, Hofmeyr and Kulier, 2012, Hutton andHofmeyr, 2006), induc-
tion of labor for PROM (Buchanan et al., 2010), antibiotics for PROM
(Kenyon et al., 2013, Cousens et al., 2010), active management for
third stage of labor (McDonald et al., 2013,), thermal care (McCall et
al., 2010), neonatal resuscitation with bad and mask (Lee et al., 2011),
presumptive antibiotic therapy for newborn (Ungerer et al., 2004,),
Comprehensive care of children infected or exposed to HIV infection
(Grimwade and Swingler, 2006), Vitamin A as part of treatment for
non-measles-associated pneumonia for children above 6 months (Wu
et al., 2005), and case management of diarrhea (Yakoob et al., 2011).
5. Discussion
There have been many great successes in reducing neonatal mortal-
ity as part of the MDGs, however, the current rates are still too high
since each year 2.9 million newborns do not live to their ﬁrst month
of life (Berkley et al., 2014). In order to accelerate the progress towards
reaching the targets set for 2015, this overview aimed to identify key
interventions for neonatal and later survival. Review of all the recent
Cochrane and other reviews on pre-pregnancy, pregnancy, neonatal
and child health interventions which have reported perinatal or neona-
tal and child mortality identiﬁed six highly effective and 11 promising
interventions which are likely to improve health and survival among
babies. During the past decade, notable advances have been made in
reviewing the evidence base for newborn interventions (Bhutta et al.,
2013, 2014), especially in the context of essential interventions,
packages of care and their interconnections (Lassi et al., 2013a).
The key effective interventions for improving the survival identiﬁed
in this overview include antenatal corticosteroids for preventing neona-
tal RDS in preterm infants; early initiation of breastfeeding; hygienic
cord care; KMC for preterm infants; provision and promotion of use of
ITNs for children; and vitamin A supplementation for infants from six
months of age. Among these, four are particularly effective for neonates,
while two had clear implications for improving the survival among in-
fants and children.Most of the interventions identiﬁed are very effective
for premature infants, as deaths from preterm births complications are
the leading cause for neonatal deaths (Bhutta et al., 2013). Every year,
an estimated 15 million babies are born preterm. Of these over one
million die. The common cause of neonatal mortality is RDS which is
related to prematurity. The incidence of mortality due to prematurity
is highest in LMIC (Blencowe et al., 2012) where even moderately
preterm babies strive for survival. Preventing deaths from preterm
births, is therefore of the utmost importance. Administration of antena-
tal corticosteroids towomen at risk of preterm birth can prevent deaths
among babies related to RDS. This overview further suggests that the
risk of deaths among those who are born too soon can be halved
(50%) by encouragingKMCwhich not only ensures skin-to-skin contact,
but promotes breastfeeding and early recognition of danger signs and
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well documented; with studies suggesting much greater beneﬁts of
early vs. late feeding (Debes et al., 2013). Early initiation of
breastfeeding can reduce neonatal deaths by 44%. At the same time
hygienic cord care can further reduces mortality by 23%. For children
under the age of ﬁve years, infections accounts for a large number of
deaths. Prevention of malaria particularly in malaria endemic countries
can ensure 18% reduction in mortality. Provision of vitamin A for
children above 6 months of age, which decreases the susceptibility
towards infection, can also improve survival and health.
Despite the clear evidence of these interventions, coverage is still
low and therefore their impact to reduce mortality among newborns
and children is very poor. The recent Lancet every newborn series
(Bhutta et al., 2013, 2014) has clearly highlighted that approximately
three-quarters of deaths under ﬁve years can be averted if countries im-
plement interventions at a coverage of 70–90% by 2025 (Bhutta et al.,
2013). Considering the example of TT immunization, it is quite evident
that 60% increase in coverage in last 25 years has led to 90% reduction in
tetanus mortality in babies (Blencowe et al., 2010a). However, the
coverage for insecticide treated bed nets in 2011 is still low 35.3%
(5.2%–75.5%) and countries should prioritize mechanisms to increase
coverage (Hill et al., 2014). Moreover, effective interventions such as
hygienic cord care, which includes chlorhexidine cord cleansing, and
adopting antenatal corticosteroids for preventing neonatal respiratory
distress syndrome in preterm infants have very low coverage according
to surveys with less than a third of women and neonates in need
receiving them (Mason et al., 2014). Therefore, integrating these inter-
ventions into existing neonatal and childhood programs whereby
mothers may also receive interventions such TT immunization, ITNs
and corticosteroids when at risk at the same time may be an effective
way to increase coverage.
High coverage of available interventions by 2025 can prevent almost
three-quarters of neonatal deaths, and can save around 2 million lives
per year (Bhutta et al., 2014). Interventions delivered in packages,
especially for the care of small and ill neonates have the potential to
save 1.9 million newborn infants (Bhutta et al., 2014). Estimate suggests
that available interventions can reduce neonatal deaths related to
prematurity by 58%, intrapartumby 79% and infections by 84% among ne-
onates (Bhutta et al., 2014). Therefore, the implementation of the inter-
ventions identiﬁed in this overview will be of paramount importance
for improving neonatal and child survival especially in the countries
with the highest burden of mortality. It is vital to understand that these
interventions are central for LMICwhere neonatal and child health indica-
tors are still not up to a high standards and many lives are either lost or
their quality compromised due to a dearth of simple and effective actions
(Bhutta et al., 2005). These interventions need to be deployed to all and
promoted from the very outset, including the preconception period,
which is vital to ensuring that women of child bearing age understand
the importance of these interventions for their babies' health and survival.
A step forward to seeing improvements in annual reductions in neo-
natalmortality rates would be to paymore attention to the target group
for the interventions; funding and resources may need to be reallocated
to include stillbirth prevention which has received very little attention
so far (Frøen et al., 2011). High fertility rates may also be adding to
the problem. Care and resources in LMICs may be inadequate to cover
already existing newborns; and increasing numbers of neonates will
lead to strains on existing health care systems. Improved access to
family planning, contraceptive methods, awareness and education will
decrease the disparity and help efforts to achieve decreased neonatal
mortality rates (Bhutta et al., 2014).
Community-based delivery strategies to increase access to needed
care must be foremost to bringing about a positive change in the
LMICs because appropriate education and awareness needs to precede
interventions. Empowerment of women, removing barriers to accessi-
bility to health care services, increased education and awareness in
communities, and shifting the focus to evidence based interventionsmay help in adopting healthy practices among mothers and improve
child survival rates (Bhutta et al., 2014). Appropriate, culturally sensi-
tive education and awareness provided to the communities, followed
by timely implementation of discussed interventions which can be
integrated with existing healthcare practices, will deﬁnitely bring the
required improvement in child health and survival.
Several limitations do however need to be recognised. First, it is
important to consider that many of the interventions assessed in this re-
view demonstrated important reductions in morbidity but may have
been underpowered to show differences in neonatal and later survival.
Second, it is also important to be aware that some clearly effective inter-
ventions, such TT immunization during pregnancy for reducing tetanus
related mortality in neonates do not rate highly on GRADE, due to the
study designs required to address this issue. Third, it is not possible to ac-
count for all the biases involved in the individual primary studies during
the conduct of an overviewof systematic reviews,where only systematic
reviews and not individual primary studies are included. In addition, the
high level synthesis of an overview may not always capture important
contextual factors, such as educational attainment, socio-economic
status, and access to care.
6. Conclusion
The implementation of these interventionswill help in achieving the
targets set for MDGs 4 and 5. Adoption of effective interventions prom-
ises a much needed improvement in neonatal and child outcomes
around theworld, especially if selected depending on the clinical indica-
tions and keeping in mind the need for cost-effectiveness in view of the
limited resources in LMICs.
Research in Context
The synthesis of ﬁndings from 148 reviews on interventions for
mothers and babies showed that steroids for pregnant mothers at risk
of delivering babies early, breastfeeding, cord care, kangaroo care for
babies born early, treated bednets for children, and vitamin A for babies
from six months of age, are effective interventions for improving
survival among babies and children. Antenatal care, tetanus injection
during pregnancy, drugs to preventmalaria during pregnancy, inducing
labour during prolonged pregnancy, use of surfactant and resuscitation
to improve breathing among babies, management of infections among
babies and children, and home visits during pregnancy and postnatal
period, are the promising interventions for their survival.
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